- Trulicity, a glucagon-like peptide-1 (GLP-1) receptor agonist, is the only non-insulin, injectable diabetes treatment available in a pen with a no-see, no-handle needle INDIANAPOLIS, Nov. 25, 2014 ...

TORONTO, June 19, 2020 (GLOBE NEWSWIRE) -- New real-world data showed Trulicity ® (dulaglutide) had significantly higher adherence and longer persistence compared to weekly injections of semaglutide ...

Below is a comparison of today’s most prescribed GLP-1 medications, including Ozempic and Trulicity, both widely used for ...

Trulicity is a prescription drug prescribed to lower blood glucose levels and treat type diabetes. Although it is FDA approved for treating diabetes it is not approved for weight loss. Despite this ...

Eli Lilly on Sunday launched a DTC campaign for its injectable diabetes drug Trulicity as it seeks to build market share in the competitive GLP-1 receptor agonist class, which has four other approved ...

People with diabetes who take injectable medications like Trulicity and Ozempic have been scrambling to find their next dose. Erie-area pharmacies, like others across the country, can't get enough of ...

The U.S. Food and Drug Administration today approved Trulicity (dulaglutide), a once-weekly subcutaneous injection to improve glycemic control (blood sugar levels), along with diet and exercise, in ...

Dec 16 (Reuters) - The U.S. health regulator has added Eli Lilly and Co's (LLY.N), opens new tab Mounjaro to its list of drugs facing shortages, highlighting the company's struggles to meet booming ...

TORONTO, June 19, 2020 (GLOBE NEWSWIRE) -- New real-world data showed Trulicity® (dulaglutide) had significantly higher adherence and longer persistence compared to weekly injections of semaglutide or ...